No Detail Found!

Pharmacokinetics of a new parenteral formulation of tilmicosin-la in cows.

Author(s)
Lilia Gutiérrez Departamento de Fisiología y Farmacología, Universidad Nacional Autónoma de México
Rodrigo Soriano Departamento de Fisiología y Farmacología, Universidad Nacional Autónoma de México
Ismael Martínez-Cortes Departamento de Medicina en Rumiantes Facultad de Medicina Veterinaria y Zootecnia. Universidad Nacional Autónoma de México. Av. Universidad 3000, Delegación Coyoacán, Ciudad de México C.P. 04510, México
Jorge Miranda-Calderon Departamento de Fisiología y Farmacología, Universidad Nacional Autónoma de México
Héctor Sumano Departamento de Fisiología y Farmacología, Universidad Nacional Autónoma de México
Abstract
The blood serum pharmacokinetics of a Poloxamer-407 based new pharmaceutical preparation of 39% tilmicosin was determined in cows. Two dose levels injected SC, were assessed: 10 mg/kg (Til-LA10) and 26 mg/kg (Til-LA26). Tilmicosin was determined using HPLC, also electrocardiographic (EKG) monitoring in all animals before and at 1, 2 and 4 H after the injection of the drug was performed to measure key EKG parameters, including heart rate. Maximum serum concentration values were 2.6 μg/mL and 1.23 μg/mL, occurring 4.9 and 5.1 H after the injection of Til- LA26 and Til-LA10, respectively. Mean residence time was statistically larger for Til-LA26 (50.4±5.8 H) than Til-LA10 (37.4±4.7 H) (P
Publication Details
Page(s) 165-168
DOI DOI not available
Published Journal: Pakistan Veterinary Journal, Volume: 36, Issue: 2, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

148

Views